RecruitingNot Applicable

Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients

United States4 participantsStarted 2026-04-18

Plain-language summary

The aim of this retrospective cohort study is to compare the safety and efficacy of induction agents for tracheal intubation in critically ill adult patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Admission to the surgical ICU for critical care * Administration of one of the studied induction agents * Availability of complete clinical data Exclusion Criteria: * Age \< 18 years * Absence of documented induction agent administration * Incomplete or missing medical records

What they're measuring

Primary Outcome will be all-cause mortality at day 7 following tracheal intubation

Timeframe: day 7

Trial details

NCT IDNCT07222007

SponsorZeliha Alicikus

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2026-06-01

Contact for this trial

TOLGA SARAÇOĞLU, Prof,MD

+1 (904) 524-5932 kemaltolgasaracoglu@gmail.com

View on ClinicalTrials.gov More Critically Ill trials